24 June 2025
24 June 2025
Novo Nordisk has ended a partnership with the telehealth company that lasted less than two months.
Continued approval depends on further confirmation and detailed clinical benefit from a study.
The FDA's new AI assisted scientific review technology, named Elsa, was officially adopted by the agency on 2 June.
David W Miller, CEO of Genesis Research Group, discusses how pharma's decade-long development approach is no longer fit for purpose.
HBM7020 is developed using Harbour BioMed's HBICE technology and its Harbour Mice platform.
The acquisition marks Navamedic's entry to the field of addiction treatment.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
